Uganda is facing a growing crisis of pediatric HIV, with more than seventy thousand children aged between zero and fourteen ...

Newborns exposed to HIV during pregnancy or birth should receive preventive antiretroviral medication immediately after ...

The World Health Organization on Monday recommended Gilead's lenacapavir, a twice-yearly injection, as a tool to prevent HIV ...

Newborns exposed to HIV during pregnancy or birth should receive preventive antiretroviral medication immediately after ...

The Senate is poised to vote this week on President Donald Trump's rescissions package requesting roughly $9.4 billion in ...

LEN is the first long-acting PrEP product that requires only two injections per year, offering an appealing alternative to ...

State lawmakers unsuccessfully attempted to extend the law this year to cover the intentional exposure of other sexually ...

Freda Jones, founder of LOTUS, empowers women living with HIV in Atlanta through a peer-led support group. Peer support is ...

# Currently, about 95 percent of people living with HIV know their status. Among them, 78 percent are receiving antiretroviral therapy (ART), and 91 percent of those on ART have achieved viral ...

WHO’s director general described the policy guidelines for Gilead’s twice-yearly drug as the “next best thing” in the absence of a vaccine.

Cuts to U.S. foreign aid will endanger HIV treatment and prevention services globally and are likely to reverse decades of ...

Gilead Sciences and the Global Fund to Fight AIDS, Tuberculosis and Malaria said on Wednesday they had finalized plans to supply a long-acting HIV prevention drug to low-income countries, despite the ...